| 抗感染新药仑氨西林 |
| |
| 引用本文： | 魏敏吉 齐慧敏 王进 肖永红 林永彬 宋爱刚 王文笙. 抗感染新药仑氨西林[J]. 中国临床药理学杂志, 2005, 21(5): 387-389 |
| |
| 作者姓名： | 魏敏吉 齐慧敏 王进 肖永红 林永彬 宋爱刚 王文笙 |
| |
| 作者单位： | [1]北京大学临床药理研究所,北京100083 [2]山东鲁抗医药股份有限公司,山东济宁272021 |
| |
| 摘 要： | 仑氨西林是氨苄西林的前体药物，口服后水解成氨苄西林而在体内发挥抗菌作用，其口服吸收优于氨苄西林。本文对仑氨西林的药理、药代、临床研究情况做一综述，为临床应用提供参考。
|
| 关 键 词： | 仑氨西林 抗菌 药代动力学 |
| 文章编号： | 1001-6821（2005）05-0387-03 |
| 收稿时间： | 2004-07-28 |
| 修稿时间： | 2004-07-282005-04-15 |
New antimiaobial agent, lenampicilin |
| |
| WEI Min-ji, QI Hui-min, WANG Jin, XIAO Yong-hong, LIN Yong-bin, SONG Ai-gang, WANG Wen-sheng. New antimiaobial agent, lenampicilin[J]. The Chinese Journal of Clinical Pharmacology, 2005, 21(5): 387-389 |
| |
| Authors: | WEI Min-ji QI Hui-min WANG Jin XIAO Yong-hong LIN Yong-bin SONG Ai-gang WANG Wen-sheng |
| |
| Affiliation: | 1. Institute of Clinical Pharmacology, Peking University, Belting 100083, China ; 2. Shandong Lukang Pharmaceutical Co. Ltd, Jining 272021, China |
| |
| Abstract: | Lenampicillin is a prodrug of ampicillin. After oral administration, lenampicillin is hydrolyzed to ampicillin which is responsible for the antimicrobial activities in vivo. Lenampicillin shows better oral absorption than ampicillin. In this article, the pharmacology, pharmacokinetics and clinical studies of lenampicillin were reviewed . It may be helpful for the doctor in prescribing lenampicillin. |
| |
| Keywords: | lenampicillin antiinfection pharmacokinetics |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
